Corning Expands Into Biotech Chips
Summary: Corning, a contender in Drip Port's new high-growth company study, is using its core technologies and production capacity to enter the competitive, emerging DNA biochip market. Corning enters a field led by biochip leader Affymetrix, but Corning's technology may enable it to produce biochips 10 to 20 times faster than they are commonly produced today. Meanwhile, Corning's telecom business continues to expand.
By
Vince Hanks
October 5, 2000
Today's show features Jim Smith of Smith.com (NASDAQ: SMTH). It's been a volatile first half of the year for Pumatech (Nasdaq: PUMA), a developer of software to serve the needs of today and tomorrow's mobile Internet. The company and its technologies exploded onto investors' radar screens last year and its stock become one of the year's bang-up performers in the process. It's been a volatile first half of the year for Pumatech to serve the needs of today and tomorrow's mobile Internet.